Strong, who ruled against Kuehn in an earlier marijuana-related case, has scheduled an in-person hearing on the motions to dismiss the preemption case for May 20. The sponsors of the medical ...

Meharry fears a double whammy. First, there's the proposed 15% cap for indirect research costs from the NIH, a medical research agency overseen by the U.S. Department of Health and Human Services.

Overall, $68.7 million comes to Hawaii from the NIH. The ripple effects of this funding affect us all. Medical research creates high-paying, stable jobs that draw doctors to our communities.

manufacturers should continue asserting all available preemption defenses until the U.S. Supreme Court resolves the dispute. In Stengel v. Medtronic, Inc., a class III medical device manufactured ...

“Congress’s purpose is the ultimate touchstone in every preemption case, and here, Congress has decided to allow states to enact their own medical cannabis laws,” the ballot sponsors sai ...